BioSpace News Archive

Global health service company Cigna Corporation announced that Brian Evanko, executive vice president and chief financial officer, will present at the Wolfe Research Virtual Healthcare Conference on November 18, 2021 through a virtual webcast.

MMS Holdings (MMS) – a data-focused CRO – provided regulatory strategy support to Praxis Bioresearch in the development of a therapeutic for apathy in Alzheimer’s disease.

Sierra Donor Services, a division of DCI Donor Services, is utilizing Specialist Direct’s Telepathology for Organ Procurement Organizations to increase organ transplant rates in order to save lives.

Biotage’s profitable growth journey has continued in the third quarter with a new sales record and strong cash flow.

Ancora Heart, Inc., today announced that an analysis of early feasibility study data evaluating 12-month outcomes of the investigational AccuCinch® Ventricular Restoration System will be presented at the 33rd Transcatheter Cardiovascular Therapeutics (TCT), the annual scientific symposium of the Cardiovascular Research Foundation, in Orlando, Florida.

HighTide Therapeutics Inc., a clinical-stage biopharmaceutical company, announced today the publication of multiple abstracts highlighting positive Phase 2 clinical data with HTD1801 in patients with primary sclerosing cholangitis (PSC) and nonalcoholic steatohepatitis (NASH).

This further defines development pathways for next generation of psychedelic medicines to treat addiction.

NRGene, a leading genomics company, announces the official opening of its new office and genotyping lab in Saskatoon, Canada.

The American Society of Regional Anesthesia has chosen InSitu Biologics’ INSB200™ poster as a Best of Meeting presentation in Emerging Technologies for their 20th Annual Pain Meeting in November 2021.

The COVID-19 pandemic has resulted in an unprecedented surge in health care resource utilization.